Machine Learning

Big Joe Forklifts unveils the rugged LPX40 electric truck and Pulse telematics, aiming to replace propane fleets with smarter, greener technology.

Fresh off a massively oversubscribed IPO, Chinese robotics firm Huayan debuts at Hannover Messe, challenging industry giants with advanced AI and automation.

Entrust adds two senior executives to fortify its operations and customer success, signaling a strategic response to the rising threats and opportunities of AI.

Backed by Maria Sharapova, new startup Amulet launches a science-first supplement aiming to optimize women's performance throughout their entire cycle.

Biotech firm Epitopea adds top expert Dr. Lisa Butterfield, validating its novel RNA vaccine approach targeting hidden cancer antigens for hard-to-treat tumors.

A major tech firm's new 100,000 sq ft facility in Swanton signals a strategic corporate play and a significant economic boost for Northwest Ohio.

As PE firms struggle to turn AI hype into profit, Jefferies' strategic investment in Decision Science Advisors signals a new focus on practical results.

Acclaimed director Hirokazu Kore-eda receives a prestigious award for his artistic vision and industry advocacy, highlighting a pivotal moment for cinema.

With prestigious design awards and cutting-edge tech, DORCO's SLEEK razor is challenging established brands in North America and beyond. Here's how.

A family's personal journey with a rare disorder sparks a major investment in Quiver Bioscience's AI-powered therapy, aiming to treat Dup15q syndrome.

A top honor from the American Journal of Nursing for its CourseConnect platform extends Springer Publishing's 14-year winning streak and highlights a new era.

Constellation Kidney Group's new RCM Intelligence uses AI to help dialysis providers navigate complex billing, reduce costly denials, and improve cash flow.

As women in midlife turn to drugs like Ozempic, a new crisis is emerging: significant muscle loss. A new approach aims to protect metabolic health.

New data shows first-in-class drug tegavivint successfully inhibits the Wnt pathway, a driver in 30% of solid tumors, offering hope for tough cancers.

The AI and data analytics firm's new cybersecurity certification positions it as a key partner for sensitive defense missions in a shifting compliance landscape.

A new firm founded by industry veterans aims to solve the chip shortage by providing the hands-on engineering expertise needed to build complex new fabs.

Israel's parliament passes a major R&D tax overhaul, offering huge credits to counter global tax reforms and secure its 'Startup Nation' status.

In a major strategic shift, Old Republic has spun off its TPA division into Lodestar, a new independent brand aiming for growth in a competitive market.

A new partnership introduces PBSerum®, a biologically inspired enzyme treatment, aiming to redefine skin quality in the multi-billion dollar aesthetics market.

L2L's new Execution AI, built on AWS, promises to move factories from reactive chaos to proactive intelligence, addressing a decade of stagnant output.